Bevacizumab-associated osteonecrosis of the jaw

Ann Oncol. 2008 Dec;19(12):2091-2. doi: 10.1093/annonc/mdn653. Epub 2008 Oct 31.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bevacizumab
  • Breast Neoplasms / drug therapy*
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Female
  • Humans
  • Jaw Diseases / chemically induced*
  • Maxillary Sinusitis / complications
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Osteonecrosis / chemically induced*
  • Tooth Diseases / complications

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Doxorubicin